On October 27, 2025, Northwest Biotherapeutics Inc. signed a $5,505,000 loan agreement with Streeterville Capital, LLC, with no repayments for the first 8 months and an interest rate of 8% per annum, to fund ongoing operations.
AI Assistant
Northwest Biotherapeutics Inc
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.